Serum sclerostin and sympathetic skin response: relationship with myeloma bone disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1687-8329
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Serum sclerostin and sympathetic skin response: relationship with myeloma bone disease ; volume:58 ; number:1 ; day:11 ; month:6 ; year:2022 ; pages:1-8 ; date:12.2022
The Egyptian journal of neurology, psychiatry and neurosurgery ; 58, Heft 1 (11.6.2022), 1-8, 12.2022
- Creator
-
Omran, Alaa A.
Nageeb, Rania S.
Waley, Ahmad Barakat
Nageeb, Ghada S.
Eisa, Mohamad
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41983-022-00509-2
- URN
-
urn:nbn:de:101:1-2022080706553221756067
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Omran, Alaa A.
- Nageeb, Rania S.
- Waley, Ahmad Barakat
- Nageeb, Ghada S.
- Eisa, Mohamad
- SpringerLink (Online service)
Other Objects (12)
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
The effect of sclerostin inhibition on bone microenvironment and breast cancer bone metastases
Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects
Serum sclerostin levels in renal cell carcinoma patients with bone metastases
Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis
Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
Sclerostin and Cardiovascular Disease
The protective effect of the Wnt inhibitor sclerostin in inflammatory bone destruction
The roles of sclerostin and irisin on bone and muscle of orchiectomized rats
Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis
Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
The effect of sclerostin inhibition on bone microenvironment and breast cancer bone metastases
Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects
Serum sclerostin levels in renal cell carcinoma patients with bone metastases
Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis
Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
Sclerostin and Cardiovascular Disease
The protective effect of the Wnt inhibitor sclerostin in inflammatory bone destruction
The roles of sclerostin and irisin on bone and muscle of orchiectomized rats
Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis
Targeting loop3 of sclerostin preserves its cardiovascular protective action and promotes bone formation
Association of Serum Sclerostin with Bone Sclerostin in Chronic Kidney Disease is Lost in Glucocorticoid Treated Patients
Anti-Sclerostin Antibody Inhibits Internalization of Sclerostin and Sclerostin-Mediated Antagonism of Wnt/LRP6 Signaling
The effect of sclerostin inhibition on bone microenvironment and breast cancer bone metastases
Sclerostin antibody stimulates periodontal regeneration in large alveolar bone defects
Serum sclerostin levels in renal cell carcinoma patients with bone metastases
Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis
Osteocytic oxygen sensing controls bone mass through epigenetic regulation of sclerostin
Sclerostin and Cardiovascular Disease
The protective effect of the Wnt inhibitor sclerostin in inflammatory bone destruction
The roles of sclerostin and irisin on bone and muscle of orchiectomized rats
Serum levels of sclerostin reflect altered bone microarchitecture in patients with hepatic cirrhosis